Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Blueprint Medicines
AddedFeb 19, 2024
UpdatedJun 18, 2026
Blueprint Medicines

Blueprint Medicines

Public

Blueprint Medicines, based in Cambridge, US, develops targeted cancer treatments for genomically defined patients.

HQ
Cambridge, MA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Blueprint Medicines, founded in Cambridge, US, is dedicated to developing targeted cancer treatments for genomically defined patients. The company's core mission is to improve patient outcomes by creating precision therapies that address the molecular underpinnings of cancer. Blueprint Medicines offers a range of products, including AYVAKIT®/AYVAKYT® (avapritinib), which targets specific genetic mutations in cancer cells. Their market focus is on providing innovative solutions for patients with rare and difficult-to-treat cancers.

Notable affiliated individuals include industry experts and seasoned professionals in biomedical research and oncology. The company has attracted significant investment from leading healthcare investors. Key achievements include presenting promising clinical data at major conferences such as EAACI, EHA, and ASCO, highlighting the sustained benefits of their therapies. Blueprint Medicines has made a substantial impact on the field of precision oncology, offering hope and improved treatment options for patients with genetically defined cancers.

Blueprint Medicines - Similar Companies

BeOne Medicines logo

BeOne Medicines

beigene.com

Foundation Medicine logo

Foundation Medicine

Revolution Medicines logo

Revolution Medicines

revmed.com

Clovis Oncology logo

Clovis Oncology

Accelerated Pharma logo

Accelerated Pharma

Seagen logo

Seagen

seagen.com

xCures logo

xCures

xcures.com

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

Verastem logo

Verastem

Kronos Bio logo

Kronos Bio

Exelixis logo

Exelixis

exelixis.com

G1 Therapeutics logo

G1 Therapeutics

g1therapeutics.com

Arvinas logo

Arvinas

arvinas.com

Novocure logo

Novocure

novocure.com

Praxis Precision Medicines logo

Praxis Precision Medicines

Blueprint Medicines - Quick Facts

Who are Blueprint Medicines' competitors?

Companies similar to Blueprint Medicines include BeOne Medicines, Foundation Medicine, Revolution Medicines and Clovis Oncology.

When was Blueprint Medicines founded?

Blueprint Medicines was founded in 2008.

Where is Blueprint Medicines' headquarters located?

Blueprint Medicines' headquarters is located in Cambridge, MA, US.

When was Blueprint Medicines' last funding round?

Blueprint Medicines' most recent funding round was for $1.3B (USD) in June 2022.

How much has Blueprint Medicines raised to-date?

As of Jun 30, 2022, Blueprint Medicines has raised a total of $2.4B (USD).

How many employees does Blueprint Medicines have?

Blueprint Medicines has 641 employees as of Feb 6, 2024.

Blueprint Medicines - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatments
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering